Human Genome to get U.S. govt anthrax drug deal (Reuters)


Reuters - Human Genome Sciences Inc. plans to
announce a deal with the U.S. government on Monday to provide
as many as 100,000 doses of an experimental anthrax drug, the
Washington Post reported.